Serum estradiol should be monitored not only during the peri-menopausal period but also the post-menopausal period at the time of aromatase inhibitor administration

BACKGROUND: Aromatase inhibitor (AI) therapy is being extensively used as postoperative adjuvant therapy in patients with hormone receptor-positive postmenopausal breast cancer. On the other hand, it has been reported that ovarian function was restored when AI was administered to patients who had un...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Nagao, Taeko, Kira, Misako, Takahashi, Masako, Honda, Junko, Hirose, Toshiyuki, Tangoku, Akira, Zembutsu, Hitoshi, Nakamura, Yusuke, Sasa, Mitsunori
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2009
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2779795/
https://ncbi.nlm.nih.gov/pubmed/19909552
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1477-7819-7-88
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados